Transcranial static magnetic stimulation for amyotrophic lateral sclerosis: a bicentric, randomised, double-blind placebo-controlled phase 2 trial
-
Published:2024-10
Issue:
Volume:45
Page:101019
-
ISSN:2666-7762
-
Container-title:The Lancet Regional Health - Europe
-
language:en
-
Short-container-title:The Lancet Regional Health - Europe
Author:
Di Lazzaro VincenzoORCID,
Ranieri FedericoORCID,
Doretti Alberto,
Boscarino Marilisa,
Maderna Luca,
Colombo EleonoraORCID,
Soranna Davide,
Zambon Antonella,
Ticozzi Nicola,
Musumeci Gabriella,
Capone Fioravante,
Silani VincenzoORCID
Reference49 articles.
1. Hyperexcitability, neurodegeneration, and disease progression in amyotrophic lateral sclerosis;Kiernan;Muscle Nerve,2023
2. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights;Vucic;J Neurol Neurosurg Psychiatry,2013
3. History of ALS and the competing theories on pathogenesis: IFCN handbook chapter;Eisen;Clin Neurophysiol Pract,2023
4. Cortical hyperexcitability in the driver’s seat in ALS;Gunes;Clin Transl Neurosci,2022
5. Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension;Vucic;EClinicalMedicine,2023